Australia's CardieX jumps most in over 22 weeks on unit's services deal

Conneqt Health

09/12/2022 04:00

** Shares of Australian medical device maker CardieX Ltd
 CDX.AX  soar as much as 33.9% to A$0.415, on track for their
biggest pct gain since July 6 
    ** Co signs new clinical trial services agreement for the
provision of its arterial health device XCEL and data management
services by unit ATCOR  urn:newsml:reuters.com:*:nFWN32Y1N0
    ** Shares hit their highest level since July. 26  
    ** More than 118,000 shares change hands as compared with
the 30-day average volume of ~88,240 shares  
    ** Stock down 55.1% this year, as of last close, vs a 3.6%
decrease in the benchmark S&P/ASX 200 index  .AXJO  
 (Reporting by Roushni Nair in Bengaluru)
 ((Roushni.Nair@thomsonreuters.com;))